Pharma News, 2021

Glenmark Pharmaceuticals, a research-led, global integrated pharmaceutical company, today announced interim data of 503 patients from its Post Marketing Surveillance (PMS) study on Favipiravir...

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has approved AbbVie and Roche’s Venclyxto for the treatment of newly diagnosed acute myeloid leukaemia (AML).

The FDA's controversial decision to approve Biogen and Eisai's Alzheimer's disease treatment Aduhelm (aducanumab) has prompted a third member to resign from the advisory committee ...

(Reuters) -Europe's drug regulator on Friday identified another very rare blood condition as a potential side effect of AstraZeneca's COVID-19 vaccine and said it was looking into case...

UMass Medical School scientists Katherine A.

Astellas’ oral treatment Xtandi has received approval from the National Institute for Health and Care Excellence (NICE) for the treatment of metastatic hormone-sensitive prostate cancer (...

German pharma company Bayer has announced that it has made progress in its ‘two-pronged’ approach to deliver cell and gene therapy candidates for the treatment of Parkinson’s disease.

The initial outbreak of the COVID-19 pandemic delayed merger and acquisitions in the pharma sector, but evidence points to an uptick in activity because the rationale for sealing deals hasn’t change...

A day after the FDA's landmark decision to grant accelerated approval to Biogen's Alzheimer's disease drug Aduhelm (aducanumab), company executives on Tuesday were asked to explain...

Merck has struggled to develop therapeutics and vaccines to fight COVID-19.

BURLINGTON, ON.

Another year, another major vaccine approval for Pfizer.